AGL Energy Limited

AGL.AX Q2 2026

Reported: 2026-02-11

AGL Energy delivered solid operational performance in the first half of FY '26, demonstrating resilience with stable EBITDA and an interim dividend declaration, despite an increased depreciation burden and higher finance costs.

Key takeaways

EBITDA remained flat, with underlying net profit pressured by increased depreciation and a rise in finance costs due to higher borrowings.
Customer satisfaction metrics improved significantly, with a score of 83.8 and a strong customer services growth, particularly from energy services.
The flexible asset fleet achieved a premium of 20% over the market price, indicating strong pricing power despite lower market volatility.
AGL narrowed its FY '26 financial guidance, reflecting confidence in sustaining operational momentum and growth initiatives.
The construction of significant battery projects continues, with capacity targets contributing towards AGL’s strategic aim of 6 gigawatts of renewable and firming capacity by 2030.

View recap

Commonwealth Bank of Australia

CBA.AX Q2 2026

Reported: 2026-02-11

Commonwealth Bank of Australia reported a 6% increase in cash net profit for the half year ended December 31, 2025, alongside a fully franked dividend rise to $2.35, reflecting strong customer engagement and disciplined growth amid a competitive market.

Key takeaways

Cash net profit rose by 6%, with earnings per share increasing by $0.19 year-over-year.
Strong mortgage and business lending growth at 7% and 12% respectively, marking the best domestic deposit and lending growth since 2008.
Operating income grew by 6.6%, while operating expenses increased by 5.5% due to inflation and strategic investments in technology.
Maintained top Net Promoter Score positions in retail and institutional banking, emphasizing deep customer relationships.
Loan losses remained minimal at 6 basis points, underscoring strong credit quality amid robust lending growth.

View recap

CSL Limited

CSL.AX Q2 2026

Reported: 2026-02-11

CSL reported a mixed performance for H1 FY2026, with group revenue down 4% and a significant reported net profit decline of 81%, primarily due to transformation costs and government policy impacts. Despite these challenges, the company remains committed to its strategic transformation and growth ambitions.

Key takeaways

Group revenue decreased by 4% and NPATA dropped by 7%, reflecting ongoing market pressures.
Reported net profit after tax was severely impacted, down 81%, influenced by one-off costs and asset impairments.
CSL announced the expansion of its share buyback program from $500 million to $750 million, signaling confidence in cash flow stability.
The strategic transformation continues to progress, with initiatives expected to yield stronger growth and profitability in the second half of the year.
Behring remains a focal point for growth, with new product launches anticipated to drive revenue recovery.

View recap

CSL Limited

CSLLY Q2 2026

Reported: 2026-02-11

CSL reported a challenging first half for FY 2026, with revenue declining 4% and a significant drop in net profit after tax, reflecting one-off costs and government policy impacts, but remains committed to a robust transformation strategy.

Key takeaways

Revenue fell 4% on a constant currency basis, with NPATA down 7%.
Net profit after tax plummeted 81% due to one-off transformation costs and asset impairments.
Strong operational cash flow of $1.3 billion; share buyback program expanded from $500 million to $750 million.
Strategic transformation initiatives are progressing well, targeting simplified operations and enhanced growth.
Guidance for the full year remains unchanged, with optimism for recovery driven by Ig, albumin, and new product launches.

View recap

Electromed, Inc.

ELMD Q2 2026

Reported: 2026-02-11

Electromed, Inc. delivered a standout performance in Q2 FY 2026 with record revenue of $18.9 million, marking the thirteenth consecutive quarter of revenue and profit growth, despite a strategic pullback in hospital shipments.

Key takeaways

Revenue increased by 16.3% year-over-year, driven by an 18.4% rise in the Home Care segment.
Operating income grew 42.4% year-over-year to $3 million, with an operating income margin of 19%.
The "Triple Down on Bronchiectasis" campaign launched to target a significant unmet need in bronchiectasis care, addressing potential expansion to 800,000 underserved patients.
25 new payer contracts were secured, expanding coverage to an additional 2.9 million lives, enhancing market access for SmartVest.
Implementation of digital solutions, including the Smart Order e-prescribe, streamlined order fulfillment, with over one-third of orders now processed through this platform.

View recap

Siemens Energy AG

ENR.DE Q1 2026

Reported: 2026-02-11

Siemens Energy achieved a record-breaking Q1 in FY 2026, with order bookings reaching nearly EUR 18 billion, driven by strong demand across multiple sectors and robust execution of its backlog.

Key takeaways

Order backlog increases to EUR 146 billion, providing strong visibility for future performance.
Gas Services reports its strongest quarter ever with 102 gas turbines booked, reflecting over 50% of last year's annual volume in just one quarter.
Grid Technologies sees significant growth in the Americas, with orders up nearly 60% on a comparable basis and revenue increasing by approximately 25%.
Underlying demand for renewable energy integration and grid stabilization remains strong across all regions, highlighting the company's strategic positioning amid shifting energy trends.
Profitability improvements at Siemens Gamesa progress towards breakeven, supported by enhanced productivity and cost management.

View recap

Evolution Petroleum Corporation

EPM Q2 2026

Reported: 2026-02-11

Evolution Petroleum reported robust fiscal Q2 2026 results, with a 41% year-over-year increase in adjusted EBITDA, as a balanced asset mix and successful cost management drove profitability despite a challenging commodity price environment.

Key takeaways

Adjusted EBITDA rose 41% year-over-year, even with only a 2% increase in revenue, highlighting strong operational leverage.
Continued success in diversifying through minerals and royalty investments, with accelerated production adding incremental cash flow.
Operating costs decreased across several assets, enhancing operating margins and profitability.
Strategic flexibility in capital management allows Evolution to adapt to changing market conditions, preserving capital and maximizing returns.

View recap

NanoXplore Inc.

GRA.TO Q2 2026

Reported: 2026-02-11

NanoXplore reported a comprehensive recovery in its operating performance for Q2 2026, marked by improvements in revenue, gross margin, and adjusted EBITDA, while strategically pivoting away from lower-return investments.

Key takeaways

Revenues decreased by 17% year-over-year to $27.6 million, mainly due to lower demand from two major customers, but these volumes stabilized during the quarter.
The company opted not to proceed with a $100 million investment in the coated spherical purified graphite project, reallocating resources to higher-return opportunities.
Progress on the dry process graphene platform is on track for operational readiness by early April, expected to enhance cost efficiency and market access.
Successful launch of partnerships, including a key agreement with Club Car, along with a new contract with Volvo Trucks estimated to generate CAD 9-10 million annually, strengthen revenue visibility.
Strategic collaboration with Chevron Phillips Chemical shows promise with active field testing and early shipments, diversifying revenue into high-margin applications.

View recap

Grasim Industries Limited

GRASIM.NS Q3 2026

Reported: 2026-02-11

Grasim Industries reported strong Q3 FY '26 earnings, driven by substantial growth in its Paints segment, Birla Opus, which significantly outperformed the industry.

Key takeaways

Birla Opus sales volume surged 70% year-on-year, with revenue market share increasing by over 300 basis points.
The company crossed 500 million liters in cumulative paint sales within 18 months and expanded its market presence to 10,400 towns.
Institutional sales grew by 40% quarter-on-quarter, with a strong project pipeline of over 40,000 ongoing negotiations.
Launch of a digital platform to enhance contractor engagement and broaden consumer reach, connecting over 750,000 contractors nationwide.
The product portfolio was expanded rapidly, introducing 40 new products this year, enhancing brand differentiation.

View recap

Kelly Partners Group Holdings Limited

KPG.AX Q2 2026

Reported: 2026-02-11

Kelly Partners Group Holdings Limited reported robust revenue growth of 17% for the first half of 2026, driven by a successful global expansion strategy and strong cash flow metrics.

Key takeaways

Revenue run rate increased by 22%, reflecting continued operational momentum.
Free cash flow per share grew by 10%, exhibiting effective cost management and profitability.
The company expanded its international footprint by entering the Irish market and maintaining 51% ownership in the Kudos network.
Strong return on invested capital, complemented by a successful programmatic acquisition strategy, positions KPG favorably amidst potential market downturns.
The firm is actively investing in proprietary software and AI integration, enhancing its competitive advantage in the evolving accounting landscape.

View recap

Ceconomy AG

MTTRY Q1 2026

Reported: 2026-02-11

CECONOMY reported strong Q1 results for fiscal year 2025-2026, showcasing consistent growth in sales and profitability despite a competitive retail landscape.

Key takeaways

Sales grew by 3.4% to €7.6 billion, while adjusted EBIT increased by 11% to €311 million, marking the 12th consecutive quarter of profitability growth.
Online share reached a record high of 30%, with online sales up 6.9%, reflecting successful omnichannel strategy execution.
Net Promoter Score (NPS) rose to an all-time high of 61, indicating enhanced customer satisfaction and loyalty.
The number of loyalty program members surged to 57 million, demonstrating increased customer engagement.
Strong performance in international markets, notably in Turkiye, Spain, and Hungary, balanced out softer demand in Germany and Austria.

View recap

Prospect Capital Corporation

PSEC Q2 2026

Reported: 2026-02-11

Prospect Capital reported strong performance in Q2 FY2026, delivering a net investment income of $91 million and focusing on asset rotation toward first lien senior secured loans, which now comprise 71.4% of the portfolio.

Key takeaways

Net investment income of $91 million equates to $0.19 per common share with NAV at approximately $3 billion.
Increased first lien senior secured loans by 728 basis points since June 2024, now making up 71.4% of investments.
Successfully reduced exposure to second lien loans and subordinated structured notes, with the latter near zero, enhancing portfolio quality.
Monthly common shareholder distributions maintained at $0.045 per share for February through April.
Interest income constituted 92% of total investment income, showcasing strong recurring revenue.

View recap

Renishaw plc

RSW.L Q2 2026

Reported: 2026-02-11

Renishaw reported a strong first half with revenue growth of 7.1%, driven by robust demand in the Americas and APAC, notwithstanding mixed market conditions and challenges in EMEA. The company anticipates continued revenue and profit growth, supported by strategic investments in emerging businesses.

Key takeaways

Revenue growth of 7.1% reported; 11.5% at constant currency, with gains across all segments.
Strong 15% growth in the Americas, boosted by high-value capital equipment demand and pricing adjustments.
Operating profit increased by 11.4% to GBP 57.5 million, with a 0.6% improvement in operating margin despite currency headwinds.
Cost reduction initiatives contributed to an 8.5% reduction in gross engineering costs, supporting margin improvement.
Company confirmed an unchanged dividend payment of 16.8p amidst strong operational performance.

View recap

Veru Inc.

VERU Q1 2026

Reported: 2026-02-11

Veru Inc. delivered a robust performance in Q1 FY2026, marked by significant progress in its clinical trials and regulatory developments for its obesity treatment candidates, Novosarm and cabozantinib.

Key takeaways

The Phase 2b clinical trial for Novosarm demonstrated proof of concept for selective fat loss while preserving lean mass in older patients, a critical advancement in obesity treatment.
Regulatory discussions with the FDA confirmed two potential pathways for approval, enhancing the strategic outlook for Novosarm in combination with GLP-1 receptor agonists.
The FDA's recent acknowledgment of bone mineral density as a validated surrogate endpoint could open new opportunities for Novosarm’s development in postmenopausal women with obesity and osteoporosis.
Veru continues to address challenges in GLP-1 treatments, with Novosarm potentially providing solutions for patients who experience weight loss plateaus on current therapies.

View recap

Varex Imaging Corporation

VREX Q1 2026

Reported: 2026-02-11

Varex Imaging reported a strong start to FY 2026 with Q1 revenues of $210 million, reflecting a 5% year-over-year increase, driven primarily by robust performance in the Industrial segment.

Key takeaways

Industrial segment revenue surged 17% year-over-year, supported by high demand in cargo systems and nondestructive testing applications.
Non-GAAP gross margin reached 34%, benefiting from a favorable product sales mix, aligning with guidance.
Non-GAAP EBITDA rose to $29 million, a 12% increase year-over-year, while Non-GAAP EPS improved to $0.19, up from $0.10.
Customer engagement at RSNA highlighted positive trends in demand, with increased focus on next-generation system designs and strong sales trends in certain medical modalities.
Varex's integrated modality-based approach to product offerings is expected to enhance customer partnerships and drive long-term revenue growth through system-level design wins.

View recap

Earnings Recaps

AGL Energy Limited

Commonwealth Bank of Australia

CSL Limited

CSL Limited

Electromed, Inc.

Siemens Energy AG

Evolution Petroleum Corporation

NanoXplore Inc.

Grasim Industries Limited

Kelly Partners Group Holdings Limited

Ceconomy AG

Prospect Capital Corporation

Renishaw plc

Veru Inc.

Varex Imaging Corporation

Community

Earnings Recaps

AGL Energy Limited

Commonwealth Bank of Australia

CSL Limited

CSL Limited

Electromed, Inc.

Siemens Energy AG

Evolution Petroleum Corporation

NanoXplore Inc.

Grasim Industries Limited

Kelly Partners Group Holdings Limited

Ceconomy AG

Prospect Capital Corporation

Renishaw plc

Veru Inc.

Varex Imaging Corporation

Community

Trending This Week

Notifications